Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the Prostaglandin E2 human model of headache

Fig. 3

Individual and mean (filled square) diameter (mm) in the superficial temporal artery (STA) on placebo day compared with BGC20-1531 before and after Prostaglandin E2 (PGE2) infusion. There was a difference between AUCSTA on BGC20-1531 200 mg pretreatment and placebo, and no difference between AUCSTA on placebo and 400 mg pretreatment (paired t test)

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us